Is the stepping‐down approach a better option than multiple daily injections in obese patients with poorly controlled Type 2 diabetes on advanced insulin therapy?

AIM: To determine whether de‐escalating from advanced insulin therapy (AIT) to the combined use of metformin, an SGLT2 inhibitor, a GLP1 receptor agonist and basal insulin is the better option than multiple daily insulin injections (MDI) in obese patients with poorly controlled T2DM. METHODS: This w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocrinol Diabetes Metab
Main Authors: Naing, Soe, Ramesh, Geeta, Garcha, Jasmine, Poliyedath, Anupama, Khandelwal, Stutee, Mills, Paul K.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029542/
https://ncbi.nlm.nih.gov/pubmed/33855207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.204
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados